Latest Headlines

  1. Outsourced Pharma Announces San Diego Conference Session Update
    7/20/2017

    Outsourced Pharma announces an agenda and panelist update for its Outsourced Pharma San Diego conference to be held in La Jolla on August 22 – 23 2017, at the Hyatt Regency La Jolla. Outsourced Pharma is a conference designed for executives at pharma and biotech sponsor companies who rely on contract development and manufacturing organizations to bring their products to market.

  2. Life Science Connect Announces The Acquisition Of Industry Standard Research
    7/17/2017

    Today Life Science Connect (LSC), a leading B2B marketing services and engagement company, announced the acquisition of Industry Standard Research (ISR), also known as ISR Reports.

  3. FDA Clears Philips’ Wearable Light Therapy Device For Psoriasis
    7/13/2017

    Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the Philips BlueControl wearable light therapy device to treat mild psoriasis.

  4. Abbott, Bigfoot Biomedical To Collaborate On Diabetes Technologies
    7/13/2017

    Abbott (NYSE: ABT) and Bigfoot Biomedical today announced that the companies have entered into an agreement to develop and commercialize diabetes management systems, integrating Abbott's FreeStyle® Libre glucose sensing technologyi with Bigfoot's insulin delivery solutions in the United States.

  5. Stryker’s MultiGen 2 RF Generator Cleared BY FDA
    7/11/2017

    Stryker announced today that it has received FDA 510(k) clearance for its MultiGen 2 RF Generator. This product provides physicians with the efficiency, control and reliability they need when performing radiofrequency ablation, a minimally invasive procedure that can provide lasting relief to those suffering from facet joint pain.1

  6. Zimmer Biomet CEO Dvorak Steps Down
    7/11/2017

    Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, announced that David C. Dvorak has stepped down as President and Chief Executive Officer and a member of the Board of Directors, effective today.

  7. FDA Approves Medtronic’s CoreValve Evolut TAVR For Expanded Indication
    7/10/2017

    Medtronic plc recently announced the expanded U.S. Food and Drug Administration (FDA) approval of the self-expanding CoreValve Evolut transcatheter aortic valve replacement (TAVR) platform to include patients with symptomatic severe aortic stenosis who are at an intermediate risk for open-heart surgery.

  8. Masimo’s rainbow Super DCI-Mini Sensor Earns CE Mark
    7/10/2017

    Masimo announced recently the CE marking of the rainbow Super DCI-mini sensor, a reusable spot-check sensor that features Masimo SET Measure-through Motion and Low Perfusion pulse oximetry and rainbow SET technology with multiple physiologic measurements – including, for the first time, the ability to measure total hemoblogin (SpHb), carboxyhemoglobin (SpCO), methemoglobin (SpMet), and arterial oxygen saturation (SpO2) using the same noninvasive reusable sensor.

  9. Entellus Medical To Acquire Spirox IN $81M Deal
    7/7/2017

    Entellus Medical, Inc. (NASDAQ:ENTL), a medical technology company focused on delivering minimally invasive ENT procedures, today announced that it has entered into a definitive agreement to acquire Spirox, Inc., a privately-held ENT medical technology company that develops, manufactures and markets the LATERA™ Absorbable Nasal Implant, a minimally invasive option for ENTs and facial plastic surgeons to treat nasal airway obstruction.

  10. Cerus Endovascular’s Neurovascular Systems Earns CE Mark Approval
    7/6/2017

    Cerus Endovascular Ltd. today announced that it has received CE Mark approval for the commercial sale of its Contour Neurovascular System™ for the treatment of intra-cranial aneurysms (IAs) across the European Union (EU).